MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

500310

Report Date :

28.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

ZYDUS WELLNESS LIMITED (w.e.f. 2009)

 

 

Formerly Known As :

CARNATION NUTRA ANALOGUE FOODS LIMITED

 

 

Registered Office :

House No. 6 and 7, Sigma Commerce Zone, Near Iscon Temple, Sarkhej – Gandhinagar Highway, Ahmedabad – 380015, Gujarat

Tel. No.:

91-79-26868100

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

01.11.1994

 

 

Com. Reg. No.:

04-023490

 

 

Capital Investment / Paid-up Capital :

INR 390.700 Million

 

 

CIN No.:

[Company Identification No.]

L15201GJ1994PLC023490

 

 

IEC No.:

[Import-Export Code No.]

0895008416

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMC00196A

 

 

GSTN :

[Goods & Service Tax Registration No.]

Not Divulged

 

 

PAN No.:

[Permanent Account No.]

AAACC7740G

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Subject is engaged into the business of manufactures and markets health and wellness products. [Registered Activity]

 

 

No. of Employees :

264 (Approximately)

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Status :

Excellent

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of ‘Cadila Healthcare Limited’ and was incorporated on 1st November 1994. The company is engaged in manufacturing and supplying of healthcare, nutrition and cosmeceuticals products.

 

For the financial year ended 2017, the company has achieved decent growth in its revenue profile and has maintained strong profit margin during the year.

 

The sound financial profile of the company is reflected by its healthy solvency indicators due to zero debt balance sheet profile along with decent net worth and base and satisfactory liquidity position.

 

Rating also takes into account of strong financial and managerial support that company receives from its holding entity backed by its well experienced management team.

 

The company is listed on BSE at the price quoted at INR 1148.50 against its face value of INR 10.

 

As per quarterly results till December 2017, the company has achieved revenue of INR 680.4 million and has clocked a net profit margin of 53.38%.

           

Trade relations are reported as fair. Payments seems to be regular and as per commitment.

 

In view of aforesaid, the company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 28.03.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED

 

Management Non-Cooperative [Tel. No.: 91-79-26868100]

 

 

LOCATIONS

 

Registered Office:

House No. 6 and 7, Sigma Commerce Zone, Near Iscon Temple, Sarkhej – Gandhinagar Highway, Ahmedabad – 380015, Gujarat, India

Tel. No.:

91-79-26868100 (20 Lines) / 67775888

Fax No.:

91-79-26862253 / 67775811

E-Mail :

dhavalsoni@zyduscadila.com

info@zyduswellness.in

investor.grievance@zyduswellness.in  

Website :

www.zyduswellness.in

 

 

Factory :

7A, 7B and 8, Saket Industrial Estate, Sarkhej Bavla Road, Village Moraiya, Taluka Sanand, District Ahmedabad, Gujarat, India

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Tarun Arora

Designation :

Whole-Time Director

Address :

B/1602, Lake Castle Apartments, Hiranandani Gardens, Powai, Mumbai-400076, Maharashtra, India

Date of Appointment :

14.05.2015

DIN No.:

07185311

 

 

Name :

Dr. Sharvil Pankajbhai Patel

Designation :

Director

Address :

16, Azad Society, Ambawadi, Ahmedabad-380015, Gujarat, India

Date of Appointment :

27.04.2009

DIN No.:

00131995

 

 

Name :

Mr. Humayun Dhanrajgir

Designation :

Director

Address :

F 37/38, Dhanraj Mahal, CSM Road, Apollo Bunder, Mumbai-400039, Maharashtra, India

Date of Appointment :

27.04.2009

DIN No.:

00004006

 

 

Name :

Mr. Ganesh Narayan Nayak

Designation :

Director

Address :

3, Ashwamegh Part V, Satellite, Ahmedabad-380015, Gujarat, India

Date of Birth/Age :

61 years

Date of Appointment :

27.07.2006

DIN No.:

00017481

 

 

Name :

Ms. Indira Jitendra Parikh

Designation :

Director

Address :

Koregaon Park, Lane No. 7, Oxford Hallmark, "B" Building, Flat No. 1001, Pune-411001, Maharashtra, India

Date of Appointment :

29.07.2009

DIN No.:

00143801

 

 

Name :

Kulin Sanjay Lalbhai

Designation :

Additional Director

Address :

Lalbaug Shahibaug, Ahmedabad-380004, Gujarat, India

Date of Appointment :

18.11.2016

DIN No.:

05206878

 

 

KEY EXECUTIVES

 

Name :

Mr. Umesh Vinodray Parikh

Designation :

Chief Financial Officer

Address :

A-302, Shyam Paradise Apartment, Near Ugti Lake Vie Science City, Sola Bhadaj Road, Ahmedabad – 380060, Gujarat, India

Date of Appointment :

07.02.2018

PAN No.:

ACCPP4496R

 

Name :

Mr. Dhaval Narendra Soni

Designation :

Company Secretary

Address :

M-5/37/291, Governments Class 1, Officers' Flats, Shastrinagar, Naranpura, Ahmedabad-380063, Gujarat, India

Date of Appointment :

31.12.2007

PAN No.:

BEWPS0561P

 

 

Name :

Mr. Pravin Shah

Designation :

Finance Department

 

 

SHAREHOLDING PATTERN

 

As on 31.12.2017

 

Category of shareholder

Total nos. shares held

Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2)

(A) Promoter & Promoter Group

2,83,43,687

72.54

 

(B) Public

1,07,28,402

27.46

 

Grand Total

3,90,72,089

100.00

 

 

 

Statement showing shareholding pattern of the Promoter and Promoter Group

 

Category of shareholder

Total nos. shares held

Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2)

A1) Indian

0.00

 

Individuals/Hindu undivided Family

4,797

0.01

 

Pankaj Ramanbhai Patel

1,599

0.00

 

Pankaj Ramanbhai Patel Tarabel Patel Family Will Trust

533

0.00

 

Pankaj Ramanbhai Patel HUF

533

0.00

 

Pritiben Pankajbhai Patel

533

0.00

 

Ramanbhai B. Patel HUF

533

0.00

 

Sharvil Pankajbhai Patel

533

0.00

 

Shivani Pankajbhai Patel

533

0.00

 

Any Other (specify)

2,83,38,890

72.53

 

Cadila Healthcare Limited

2,81,63,755

72.08

 

Pripan Investments Private Limited

640

0.00

 

Zydus Family Trust

1,74,495

0.45

 

Sub Total A1

2,83,43,687

72.54

 

A2) Foreign

0.00

 

A=A1+A2

2,83,43,687

72.54

 

 

Statement showing shareholding pattern of the Public shareholder

 

Category & Name of the Shareholders

Total no. shares held

Shareholding % calculated as per SCRR, 1957 As a % of (A+B+C2)

B1) Institutions

0.00

 

Mutual Funds/

15,57,863

3.99

 

Reliance Capital Trustee Co. Ltd. A/C Reliance Small

11,24,803

2.88

 

Foreign Portfolio Investors

24,86,945

6.37

 

Matthews India Fund

16,70,471

4.28

 

Financial Institutions/ Banks

15,30,075

3.92

 

Life Insurance Corporation of India

12,38,775

3.17

 

Sub Total B1

55,74,883

14.27

 

B2) Central Government/ State Government(s)/ President of India

0.00

 

Central Government/ State Government(s)/ President of India

58,352

0.15

 

Sub Total B2

58,352

0.15

 

B3) Non-Institutions

0.00

 

Individual share capital upto INR 0.200 Million

21,69,055

5.55

 

Individual share capital in excess of INR 0.200 Million

6,96,539

1.78

 

Any Other (specify)

22,29,573

5.71

 

Trusts

357

0.00

 

HUF

70,657

0.18

 

NRI – Non- Repat

63,423

0.16

 

NRI – Repat

1,25,222

0.32

 

Clearing Members

40,933

0.10

 

Bodies Corporate

19,28,981

4.94

 

Prazim Trading and Investment Company Private Limited

8,24,004

2.11

 

Tarish Investment and Trading Company Private Limited

5,74,917

1.47

 

Sub Total B3

50,95,167

13.04

 

B=B1+B2+B3

1,07,28,402

27.46

 

 


 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged into the business of manufactures and markets health and wellness products. [Registered Activity]

 

 

Products :

Item Code No.

Product Description

1517

Table Margarine

 

 

Brand Names :

  • Sugar Free
  • Nutralite
  • Everyuth

 

 

Agencies Held :

Not Divulged

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

264 (Approximately)

 

 

Bankers :

Bank Name

Bank of Baroda

Branch

Ashram Road Branch, Ahmedabad, Gujarat, India

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

  • HDFC Bank Limited, Navrangpura Branch, Ahmedabad, Gujarat, India
  • BNP Paribas, Ellisbridge Branch

 

 

 

Statutory Auditor :

 

Name :

Dhirubhai Shah and Doshi

Chartered Accountants

Address :

4th floor, Aditya Building, Near Sardar Patel Seva Samaj, Mithakhali Six Roads, Ellisbridge, Ahmedabad – 380006, Gujarat, India

Tel. No.:

79-26403325 / 26

E-Mail :

info@dbsgroup.in 

Website :

www.dbsgroup.in

 

 

Cost Auditor :

Dalwadi and Associates

Cost Accountants

 

 

Secretarial Auditor :

Hitesh Buch and Associates

Practicing Company Secretary

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Company :

Cadila healthcare Limited

 

 

Partnership Firm :

Zydus Wellness - Sikkim

 

 

Fellow Subsidiaries/ Concerns:

  • Dialforhealth India Limited
  • Nesher Pharmaceuticals (USA) LLC [USA]
  • Dialforhealth Unity Limited
  • Zydus Healthcare (USA) LLC [USA]
  • Dialforhealth Greencross Limited
  • Zydus Noveltech Inc. [USA]
  • Zydus Healthcare Limited [ZHL]
  • Hercon Pharmaceuticals LLC [USA]
  • Liva Pharmaceuticals Limited
  • Zydus Healthcare S.A. (Pty) Ltd [South Africa]
  • Zydus Technologies Limited
  • Simayla Pharmaceuticals (Pty) Ltd [South Africa]
  • Alidac Pharmaceuticals Limited
  • Script Management Services (Pty) Ltd [South Africa]
  • Alidac Pharmaceuticals (Myanmar) Limited [Myanmar]
  • Zydus France, SAS [France]
  • Zydus Lanka (Private) Limited [Sri Lanka]
  • Zydus Nikkho Pharmaceutica Ltda. [Brazil]
  • Zydus Healthcare Philippines Inc. [Philippines]
  • Laboratorios Combix S.L. [Spain]
  • Zydus International Private Limited [Ireland]
  • Zydus Pharmaceuticals Mexico SA De CV [Mexico]
  • Zydus Netherlands B.V. [the Netherlands]
  • Zydus Pharmaceuticals Mexico Services Company SA De C.V. [Mexico]
  • ZAHL B.V. [the Netherlands]
  • Etna Biotech S.R.L. [Italy]
  • ZAHL Europe B.V. [the Netherlands]
  • Zydus Worldwide DMCC [Dubai]
  • Bremer Pharma GmbH [Germany]
  • Zydus Discovery DMCC [Dubai]
  • Zydus Pharmaceuticals (USA) Inc. [USA]
  • Sentynl Therapeutics Inc., USA

 

 

Enterprises significantly influenced by Directors and/or their relatives:

  • Cadmach Machinery Company Private Limited
  • Western Ahmedabad Effluent Conveyance Company Private Limited
  • Zydus Hospitals and Healthcare Research Private Limited Zandra Infrastructure LLP
  • Zydus Hospitals (Vadodara) Private Limited
  • Zydus Hospital LLP
  • Zydus Hospitals (Rajkot) Private Limited
  • C. M. C. Machinery
  • MabS Biotech Private Limited
  • Cadam Enterprises
  • Zydus Infrastructure Private Limited
  • Zandra Herbs and Plantations LLP
  • Cadila Laboratories Private Limited
  • Pripan Investment Private Limited

 


 

CAPITAL STRUCTURE

 

As on 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

45000000

Equity Shares

INR 10/- each

INR 450.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

39072089

Equity Shares

INR 10/- each

INR 390.700 Million

 

 

 

 

 

 

  1. There is no change in the numbers of equity shares at the beginning and end of the year.

 

Number of shares at the beginning and end of the year

39.073

 

  1. The Company has only one class of equity shares having a par value of INR 10/- each per share. Each holder of equity share is entitled to one vote per share. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the Annual General Meeting, except in the case of interim dividend. In the event of liquidation of the Company, the equity shareholders shall be entitled to proportionate share of their holding in the assets remaining after distribution of all preferential amounts.

 

  1. Details of Shareholder holding more than 5% of aggregate Equity Shares of INR 10/- each

            [as at March 31, 2016: INR 10/- {as at April 1, 2015: INR 10/-} each], fully paid:

 

Cadila Healthcare Limited

 

Number of Shares

28163755

% to total share holding

72.08%

 

  1. Number of Shares held by Holding Company

 

Cadila healthcare Limited

28.164

 

 

 

 

 

 

                                                                   


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET – STANDALONE

 

SOURCES OF FUNDS

31.03.2017

31.03.2016

31.03.2015

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

390.700

390.700

390.700

(b) Reserves & Surplus

5181.200

4395.000

3669.700

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

5571.900

4785.700

4060.400

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

6.800

12.200

16.000

(c) Other long term liabilities

5.400

4.200

2.100

(d) long-term provisions

1.500

1.100

1.200

Total Non-current Liabilities (3)

13.700

17.500

19.300

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

250.000

0.000

0.000

(b) Trade payables

154.300

114.600

96.000

(c) Other current liabilities

5.600

56.200

49.700

(d) Short-term provisions

51.800

3.600

284.400

Total Current Liabilities (4)

461.700

174.400

430.100

 

 

 

 

TOTAL

6047.300

4977.600

4509.800

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

173.900

199.800

215.400

(ii) Intangible Assets

1.000

1.500

228.800

(iii) Capital work-in-progress

0.900

0.700

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(v) Goodwill

228.200

228.200

0.000

(b) Non-current Investments

24.500

24.500

24.500

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

3.600

4.500

60.900

(e) Other Non-current assets

63.900

57.900

0.000

Total Non-Current Assets

496.000

517.100

529.600

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

2516.300

2068.100

978.200

(b) Inventories

62.600

36.800

41.100

(c) Trade receivables

4.600

2.700

3.300

(d) Cash and cash equivalents

2947.800

2343.000

2947.900

(e) Short-term loans and advances

13.100

6.500

8.500

(f) Other current assets

6.900

3.400

1.200

Total Current Assets

5551.300

4460.500

3980.200

 

 

 

 

TOTAL

6047.300

4977.600

4509.800

 

 

PROFIT & LOSS ACCOUNT – STANDALONE

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

2279.000

2021.900

2191.100

 

Other Income

245.500

301.200

204.500

 

TOTAL

2524.500

2323.100

2395.600

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

716.100

586.000

597.000

 

Purchases of Stock-in-Trade

3.300

3.600

8.800

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(16.400)

1.400

2.600

 

Excise  Duty

27.100

24.400

0.000

 

Employees benefits expense

199.000

180.300

157.800

 

Other expenses

465.700

451.000

496.700

 

TOTAL

1394.800

1246.700

1262.900

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

1129.700

1076.400

1132.700

 

 

 

 

 

Less

FINANCIAL EXPENSES

4.800

0.600

0.000

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

1124.900

1075.800

1132.700

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

37.000

35.500

45.500

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

1087.900

1040.300

1087.200

 

 

 

 

 

Less

TAX

(5.500)

7.700

(2.300)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

1093.400

1032.600

1089.500

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 NA

NA

NA

 

F.O.B. Value of Exports

 NA

 NA

0.600

 

TOTAL EARNINGS

NA

NA

0.600

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

 NA

NA

4.100

 

Components and Stores parts

 NA

 NA

0.400

 

TOTAL IMPORTS

0.000

0.000

4.500

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

27.99

26.43

27.88

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

886.700

801.800

797.900

Net cash flow from operating activity

881.100

788.600

692.400

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

30.06.2017

1ST Quarter

30.09.2017

2nd Quarter

31.12.2017

3rd Quarter

 

Unaudited

Unaudited

Unaudited

Net Sales

612.100

665.500

680.400

Total Expenditure

407.600

355.000

384.800

PBIDT (Excl OI)

204.500

310.500

295.600

Other Income

61.100

62.600

70.600

Operating Profit

265.600

373.100

366.200

Interest

4.000

4.100

3.900

Exceptional Items

NA

NA

NA

PBDT

261.600

369.000

362.300

Depreciation

9.300

9.300

9.400

Profit Before Tax

252.300

359.700

352.900

Tax

(1.300)

(0.700)

(8.300)

Provisions and contingencies

NA

NA

NA

Profit After Tax

253.600

360.400

361.200

Extraordinary Items

NA

NA

NA

Prior Period Expenses

NA

NA

NA

Other Adjustments

NA

NA

NA

Net Profit

253.600

360.400

361.200

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

0.74

0.49

0.55

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

495.43

748.85

663.97

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

78.29

70.94

57.84

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

18.05

29.25

27.56

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

6.43

5.33

2.55

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.08

0.04

0.10

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.04

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.08

0.04

0.11

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.03

0.04

0.11

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

235.35

1794.00

NA

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

47.98

51.07

49.72

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

18.08

20.74

24.16

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

19.62

21.58

26.83

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

12.02

25.58

9.25

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

11.89

25.37

9.16

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.92

0.96

0.90

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.64

0.00

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

12.02

25.58

9.25

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

STOCK PRICES

 

Face Value

INR 10.00/-

Market Value

INR  1148.50/-

 


 

FINANCIAL ANALYSIS

[all figures are INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

390.700

390.700

390.700

Reserves & Surplus

3669.700

4395.000

5181.200

Net worth

4060.400

4785.700

5571.900

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

250.000

Total borrowings

0.000

0.000

250.000

Debt/Equity ratio

0.000

0.000

0.045

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

2191.100

2021.900

2279.000

 

 

(7.722)

12.716

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

2191.100

2021.900

2279.000

Profit

1089.500

1032.600

1093.400

 

49.72%

51.07%

47.98%

 

 

 

ABRIDGED BALANCE SHEET – (CONSOLIDATED)

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

390.700

390.700

(b) Reserves & Surplus

 

5286.800

4481.300

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

5677.500

4872.000

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

43.300

40.600

(c) Other long term liabilities

 

5.500

4.400

(d) long-term provisions

 

7.400

5.800

Total Non-current Liabilities (3)

 

56.200

50.800

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

250.000

0.000

(b) Trade payables

 

665.000

632.000

(c) Other current liabilities

 

206.300

111.000

(d) Short-term provisions

 

13.200

11.900

Total Current Liabilities (4)

 

1134.500

754.900

 

 

 

 

TOTAL

 

6868.200

5677.700

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

794.400

589.900

(ii) Intangible Assets

 

2.700

2.600

(iii) Capital work-in-progress

 

1.300

1.900

(iv) Intangible assets under development

 

0.000

0.000

(v) Goodwill

 

228.200

228.200

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

616.400

510.400

(d)  Long-term Loan and Advances

 

7.000

7.700

(e) Other Non-current assets

 

56.000

7.500

Total Non-Current Assets

 

1706.000

1348.200

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

300.100

941.600

(b) Inventories

 

318.800

240.000

(c) Trade receivables

 

40.400

27.600

(d) Cash and cash equivalents

 

4401.600

3045.300

(e) Short-term loans and advances

 

16.200

11.000

(f) Other current assets

 

85.100

64.000

Total Current Assets

 

5162.200

4329.500

 

 

 

 

TOTAL

 

6868.200

5677.700

 

 

PROFIT & LOSS ACCOUNT– (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Income

 

4625.500

4260.200

 

Other Income

 

326.400

324.200

 

TOTAL

 

4951.900

4584.400

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

1359.800

1188.600

 

Purchases of Stock-in-Trade

 

5.100

12.100

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(39.200)

6.500

 

Excise Duty

 

319.800

293.400

 

Employees benefits expense

 

454.600

393.700

 

Other expenses

 

1534.700

1452.600

 

TOTAL

 

3634.800

3346.900

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

1317.100

1237.500

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

5.500

1.400

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

1311.600

1236.100

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

 

71.600

68.100

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

1240.000

1168.000

 

 

 

 

 

Less

TAX

 

127.200

115.600

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

 

1112.800

1052.400

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

27.89

26.43

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

UNSECURED LOAN

 

Unsecured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Short-term borrowings

 

 

Working Capital Loans from Banks

250.000

0.000

[Working capital loan which is repayable on demand, is availed at the interest rate of T-bill rate plus 5 bps. The outstanding amount of loan as at March 31, 2017 is INR 250.000 Million (as at March 31, 2016 INR Nil)]

 

 

Total

250.000

0.000

 

 

COMPANY OVERVIEW

 

Subject was incorporated on November 1, 1994 and operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite. The Company’s shares are listed on the National Stock Exchange of India Limited [NSE] and BSE Limited [BSE].The registered office of the company is located at House no. 6 & 7, Sigma Commerce Zone, Near Iscon Temple, Sarkhej-Gandhinagar Highway, Ahmedabad, Gujarat - 380015. These financial statements were authorized for issue in accordance with a resolution of the directors on May 27, 2017.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

State of the Indian economy

 

As per the latest Advanced Estimate (AE) of the Central Statistics Office (CSO), growth in India’s GDP at constant market prices (2011-12) was estimated at 7.1 per cent in 2016-17, slowing down from 7.9 per cent in the previous financial year. The reason was a sharp slowdown in investment to 1.7 per cent (5.6 per cent in the previous year). This negated the strong 8.7 per cent growth in private consumption (6.1 per cent in 2015-16). Strong growth momentum was seen in other segments as well – government consumption (20.8 per cent), exports (4.5 per cent) and imports (2.3 per cent). Growth in India’s GVA (Gross Value Added) at constant (2011-12) basic prices for the year 2016-17 was estimated to be 6.7 per cent, as compared to 7.8 per cent in 2015-16. At the sectoral level, agriculture, industry and services sectors grew at 4.4 per cent, 5.8 per cent and 7.9 per cent respectively in 2016-17. The average Wholesale Price Index (WPI) Inflation rate for 12 months (April 2016 to March 2017) was 3.7 per cent compared to -2.5 per cent during the corresponding period in 2015-16. (Source: Monthly Economic Report, Ministry of Finance, Govt. of India)

 

Remonetization impact is visible in the latest estimates notwithstanding statistical revisions. The short-term negative impact of remonetization seems to be largely behind the country; a consumption recovery is expected on account of an anticipated normal monsoon and higher rural wages. However, 2017-18 prospects also depend on a successful roll-out of GST as States agreed on 1st July 17 as the roll-out date.

 

The International Monetary Fund released an update in which India’s growth was expected to rebound to 7.2 per cent in 2017-18 and 7.7 per cent in 2018-19.

 

 

INDEX OF CHARGES:

 

Charges Registered

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

A61021176

10140169

IDBI BANK LIMITED

20/01/2009

-

27/04/2009

1112000.0

AHMEDABAD BRANCH, IDBI COMPLEX, OPP. MUNICIPALSTAFF QUARTERS, NR. LAL BUNGALOW, OFF C.G.ROADAHMEDABADGJ380006IN

2

A22609424

80032831

CENTRAL BANK OF INDIA

28/03/1998

28/09/1999

13/09/2007

7500000.0

S. M. ROAD BRANCH,AHMEDABADGJ380015IN

 

 

CONTINGENT LIABILITIES:

 

(INR in million)

PARTICULARS

31.03.2017

 

31.03.2016

Claims against the Company not acknowledged as debts

0.000

2.000

In respect of guarantees given by Banks and/or counter guarantees given by the Company

0.100

0.300

Other money for which the company is contingently liable :

 

 

i)              In respect of Sales Tax matters pending before appellate authorities

67.000

68.000

ii)             In respect of Income Tax matters pending before appellate authorities

0.000

6.600

 

 

 

 

 

STATEMENT OF RESULTS FOR THE QUARTER ENDED AND NINE MONTHS ENDED 31.12.2017

 

 (INR In Million)

Particulars

3 Months ended

 

Year to date figures for the current period ended

 

31.12.2017

30.09.2017

31.12.2016

1. Income from operations

 

 

 

a) Net sales/ Income from operation (net of excise duty)

680.400

665.500

1958.000

b) Other Income

70.600

62.600

194.400

Total income from Operations(net)

751.000

728.100

2152.400

2.Expenditure

 

 

 

Cost of material consumed

213.200

195.900

591.600

Purchases of stock in trade

0.000

0.000

0.100

Changes in inventories of finished goods, work-in-progress and stock-in-trade

6.200

(12.200)

(2.700)

Excise Duty

0.000

0.000

7.300

Employees benefit expenses

65.600

58.100

181.000

Finance Cost

3.900

4.100

11.900

Depreciation and amortization expenses

9.400

9.300

27.900

Advertisement and sales promotion expenses

23.200

14.900

92.000

Other expenditure

76.600

98.300

278.200

Total expenses

398.100

368.400

1187.300

 

 

 

 

Profit from ordinary activities before tax Expense:

352.900

359.700

965.100

Tax expenses

(8.300)

(0.700)

(10.100)

Net Profit / (Loss) from ordinary activities after tax

361.200

360.400

975.200

Non-Controlling Interest

0.000

0.000

0.000

Net Profit After tax and Non-Controlling Interest

361.200

360.400

975.200

Other Comprehensive

 

 

 

Items that will not be reclassified to profit or loss

2.000

4.400

6.000

Items that will not be reclassified to profit or loss

0.000

0.000

0.000

Other comprehensive Income

2.000

4.400

6.000

Total Comprehensive Income

363.200

364.800

981.200

 

 

 

 

Total Comprehensive Income attributable to:

 

 

 

Owners of the company

363.200

364.800

981.200

Non-Controlling interest

0.000

0.000

0.000

 

 

 

 

Paid-up equity share capital (Nominal value INR 10/- per share)

390.700

390.700

390.700

16.i) Earnings per share (before extraordinary items) of INR 10/- each) (not annualised):

 

 

 

Basic 

9.24

9.22

24.96

Diluted

9.24

9.22

24.96

 


 

FIXED ASSETS

 

  • Freehold Land
  • Leasehold Land
  • Buildings
  • Plant and Equipment
  • Furniture and Fixture
  • Vehicle
  • Office Equipment

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.91

UK Pound

1

INR 91.87

Euro

1

INR 80.25

 

 

INFORMATION DETAILS

 

Information Gathered by :

PRT

 

 

Analysis Done by :

NIS

 

 

Report Prepared by :

JYO


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.